IQHQ Further Expands Presence in Boston’s Fenway Area with Strategic Acquisition of The Buckminster

03 Nov 21
by iqhq

Directly adjacent to IQHQ’s Fenway Center development, The Buckminster presents an opportunity to further scale the company’s iconic, state-of-the-art life science campus

BOSTON, MA – November 2, 2021 – IQHQ, Inc., a premier life sciences real estate development company, today announced that it has completed the acquisition of The Buckminster in Boston’s Kenmore Square area. The strategic acquisition aligns with IQHQ’s ongoing development efforts in the adjacent Fenway market, which includes the $1 billion Fenway Center development and the neighboring 109 Brookline Avenue and 20 Overland Street properties, which IQHQ also acquired separately over the last two years.

“The Buckminster represents an opportunity to enhance IQHQ’s vision to develop a vibrant life science district that runs from Kenmore Square through the Fenway to the premier research, academic and medical institutes in the Longwood Medical and Academic Area,” said John Bonanno, Chief Development Officer of IQHQ. “We are excited about the promise this central and evolving location holds to connect these prominent neighborhoods and institutions.”

The Buckminster Hotel, which closed its doors in March 2020, is located at the triangular intersection of Brookline Avenue and Beacon Street. IQHQ plans to work closely with the community and City officials to bring forth an improved future for this prominent Kenmore Square site. The purchase price was not disclosed.

About IQHQ

IQHQ is giving progress a home, empowering the life science community to thrive and succeed by creating and developing environments that inspire innovation and drive progress and growth. IQHQ’s focus is to acquire, develop and operate life science properties in the innovation hubs of San Francisco, San Diego and Boston in the United States, and the Golden Triangle in the United Kingdom. IQHQ has offices in San Diego and Boston. To learn more, visit or follow us on LinkedIn or Instagram